Aitia CEO Colin Hill is participating in two AI-related panels this week in Davos, Switzerland. The first is “Reimagining Drug Discovery with Frontier AI: From Molecules to Medicine” at the AI House at 14:30 CET on January 20. The second panel is at the Davos Al Summit 2026 “IMAGINATION IN ACTION: The Inflection Of Intelligence,” which is taking place on the Luminary Stage at The Dome in Davos on January 21 at 16:30 CET. This panel discussion, “Biology Meets Intelligence: The Next Frontier in Medicine.” Colin’s remarks at both panels will focus on the massive potential – and growing impact – of Aitia’s causal AI-based extraction of deep human biological knowledge from multiple data types.